The Impact of the Tumor Microenvironment

The complexity of the tumor microenvironment presents oncology researchers with challenges and opportunities. While it can be difficult to teasing out the interaction of the many cell types or activate the immune cells in this hostile space, the TME itself can present new targets for therapy. Watch as Dr. Rhiannon Jenkinson describes how interrogating the TME with in vitro assays that effectively model this environment is a cost-effective approach to determine your candidate’s efficacy and accelerate the path to clinic. Charles River’s oncology team offers a broad selection of cell-based assays that allow you to investigate your therapeutic’s effects on the tumor microenvironment. Learn more here: https://bit.ly/3bzgITa


For over 70 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way. 

Visit our website to learn more about our portfolio and how we can support your research.   https://bit.ly/2RTdGOU